Mostrar el registro sencillo del ítem

dc.contributor.author
Martin, Maximiliano Emanuel  
dc.contributor.author
Gaete, Laura  
dc.contributor.author
Tetzlaff, Walter Francisco  
dc.contributor.author
Ferraro, Maria Florencia  
dc.contributor.author
Chiappe, Gladys Ethel  
dc.contributor.author
Botta, Eliana Elizabeth  
dc.contributor.author
Costa, Viviana Angélica  
dc.contributor.author
Saez, Maria Soledad  
dc.contributor.author
Lorenzon Gonzalez, María V.  
dc.contributor.author
Palenque, Patricia  
dc.contributor.author
Ballerini, Maria Gabriela  
dc.contributor.author
Sorroche, Patricia Beatriz  
dc.contributor.author
Boero, Laura  
dc.contributor.author
Trifone, Liliana  
dc.contributor.author
Brites, Fernando Daniel  
dc.date.available
2022-05-13T17:58:42Z  
dc.date.issued
2022-01-01  
dc.identifier.citation
Martin, Maximiliano Emanuel; Gaete, Laura; Tetzlaff, Walter Francisco; Ferraro, Maria Florencia; Chiappe, Gladys Ethel; et al.; Vascular inflammation and impaired reverse cholesterol transport and lipid metabolism in obese children and adolescents; Elsevier; Nutrition, Metabolism and Cardiovascular Diseases; 32; 1; 1-1-2022; 1-11  
dc.identifier.issn
0939-4753  
dc.identifier.uri
http://hdl.handle.net/11336/157508  
dc.description.abstract
Background and aims: Childhood obesity is associated to complications such as insulin resistance and dyslipidemia. High density lipoproteins (HDL) constitute the only lipoprotein fraction with ateroprotective properties. The aim of the present study was to analyze inflammatory markers, carbohydrate metabolism, lipid profile and HDL functionality in obese children and adolescents compared to healthy controls. Methods and results: Twenty obese children and adolescents (Body mass index z score >3.0) (9–15 years old) and 20 age and sex similar controls were included in the study. Triglyceride (TG), total cholesterol (TC), HDL-C, LDL-C, apolipoproteins (apo) A-I and B, glucose and insulin levels were quantified. Lipid indexes and HOMA-IR were calculated. Cholesterol efflux (CEC), lipoprotein associated phospholipase A2 (Lp-PLA2), lecithin-cholesterol acyl transferase (LCAT) and cholesteryl ester transfer protein, plus paraoxonase and arylesterase (ARE) activities were evaluated. Obese children and adolescents showed significantly higher TG [69 (45–95) vs 96 (76–121); p < 0.05], non-HDL-C [99 ± 34 vs 128 ± 26; p < 0.01], TC/HDL-C [2.8 ± 0.6 vs 4.7 ± 1.5; p < 0.01], TG/HDL-C [1.1 (1.0–1.8) vs 2,2 (1.4–3.2); p < 0.01], and HOMA-IR [1.5 (1.1–1.9) vs. 2.6 (2.0–4.5); p < 0.01] values, plus Lp-PLA2 activity [8.3 ± 1.9 vs 7.1 ± 1.7 umol/ml.h; p < 0,05] in addition to lower HDL-C [57 ± 10 vs 39 ± 9; p < 0.01], apo A-I [143 ± 25 vs 125 ± 19; p < 0.05], and CEC [6.4 (5.1–6.8) vs. 7.8 (5.7–9.5); p < 0.01] plus LCAT [12.6 ± 3.3 vs 18.7 ± 2.6; p < 0.05] and ARE [96 ± 19 vs. 110 ± 19; p < 0.05] activities. Lp-PLA2 activity correlated with LDL-C (r = 0.72,p < 0.01), non-HDL-C (r = 0.76,p < 0.01), and apo B (r = 0.60,p < 0.01). LCAT activity correlated with triglycerides (r = −0.78,p < 0.01), HDL-C (r = 0.64,p < 0.01), and apo A-I (r = 0.62, p < 0.05). ARE activity correlated with HDL-C (r = 0.32,p < 0.05) and apoA-I (r = 0.43,p < 0.01). CEC was negatively associated with BMI z-score (r = −0.36,p < 0.05), and triglycerides (r = −0.28,p < 0.05), and positively with LCAT activity (r = 0.65,p < 0.05). In multivariate analysis, BMI z-score was the only parameter significantly associated to CEC (r2 = 0.43, beta = −0.38, p < 0.05). Conclusion: The obese group showed alterations in carbohydrate and lipid metabolism, which were associated to the presence of vascular specific inflammation and impairment of HDL atheroprotective capacity. These children and adolescents would present qualitative alterations in their lipoproteins which would determine higher risk of suffering premature cardiovascular disease.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
OBESITY  
dc.subject
HDL  
dc.subject
REVERSE CHOLESTEROL TRANSPORT  
dc.subject
CHILDREN  
dc.subject.classification
Otras Ciencias de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Vascular inflammation and impaired reverse cholesterol transport and lipid metabolism in obese children and adolescents  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2022-05-12T06:29:29Z  
dc.identifier.eissn
1590-3729  
dc.journal.volume
32  
dc.journal.number
1  
dc.journal.pagination
1-11  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Martin, Maximiliano Emanuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Biológica; Argentina  
dc.description.fil
Fil: Gaete, Laura. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Departamento de Medicina; Argentina  
dc.description.fil
Fil: Tetzlaff, Walter Francisco. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Ferraro, Maria Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Chiappe, Gladys Ethel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Botta, Eliana Elizabeth. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Costa, Viviana Angélica. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Departamento de Medicina; Argentina  
dc.description.fil
Fil: Saez, Maria Soledad. Hospital Italiano; Argentina  
dc.description.fil
Fil: Lorenzon Gonzalez, María V.. Hospital Italiano; Argentina  
dc.description.fil
Fil: Palenque, Patricia. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Departamento de Medicina; Argentina  
dc.description.fil
Fil: Ballerini, Maria Gabriela. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Sorroche, Patricia Beatriz. Hospital Italiano; Argentina  
dc.description.fil
Fil: Boero, Laura. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Trifone, Liliana. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez". Departamento de Medicina; Argentina  
dc.description.fil
Fil: Brites, Fernando Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.journal.title
Nutrition, Metabolism and Cardiovascular Diseases  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.nmcd-journal.com/article/S0939-4753(21)00465-8/fulltext  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.numecd.2021.09.025